Intrauterine Devices Market, By Type (Hormonal IUD and Copper IUD), By Distribution Channel (Hospitals, Ambulatory Surgical Centers, Obstructive & Gynecology Clinics, and Government & Non-Profit Organizations), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2029

Report Code: PMI290319 | Publish Date: December 2023 | No. of Pages: 182

Global Intrauterine Devices Market By Overview

Prophecy Market Insights has recently published its insights on “ Intrauterine Devices Market” for the forecast period of 2018-2029. The market is segmented into By Type (Hormonal IUD and Copper IUD), By Distribution Channel (Hospitals, Ambulatory Surgical Centers, Obstructive & Gynecology Clinics, and Government & Non-Profit Organizations), and By Region.

This market is expected to witness significant growth during the forecast period on account of the gaining attention due to the rising incidence of sexually transmitted diseases and unintended pregnancies among females. In addition, it helps to control huge healthcare expenditure on abortions and other health complications of STDs. This is attributed to drive growth of the global intrauterine devices market. Governments are also taking measures to promote the use of intrauterine devices of developed and developing countries which are anticipated to propel growth of global intrauterine devices market. The global intrauterine devices market size was valued over US$ XX Bn in 2018 and is anticipated to witness more than XX% CAGR from 2019 to 2029.

North America to grow at the highest CAGR during the forecast period

North America intrauterine devices market is anticipated to dominate the global market over the forecast period, owing to launches of new products. In 2018, Europe led the market with around 38% of the market share, followed Asia pacific. Europe is anticipated to show significant growth for the global the market over the forecast period.

The research scope provides comprehensive market size, and other in-depth market information details such as, market growth supporting factors, restraining factors, trends, opportunities, market risk factors, market competition, product and services advancements and launches, product/services related regulations overview, and recent developments for the mentioned forecast period. In addition, the report provides key examination of market players operating in the specific market and analysis and outcomes related with the target market for more than 20 countries.

In the current research scope 2018 is considered as base year and 2019 is estimated year for market value/volume calculations. The report offers market estimates for the forecast period – 2019 to 2029. The report provides factual inputs and analysis based on primary and secondary research, which includes insights gained through in-depth interviews with primary research participants. Also, the data is gathered from authentic secondary sources and is verified by key opinion leaders in the target market. The in-house research is applied on gathered information to provide more accurate data points and reduce the margin of error. The in-house research and analysis efforts include various tools and 360o data analysis methodology.

The global intrauterine devices market report segments the market on the basis of type, distribution channel, and region.

The report expected to answer various target market related questions and offers insights on:

  • Definition, description, overview of market growth influencing factors, and forecast for the target market
  • Scope for related market in the forecast period
  • Analysis and outcome for the global intrauterine devices market by segment and region followed by countries
  • Market segmentation, dominating segment and region followed by country along with market value, share, Y-o-Y growth, CAGR, forecast, and contribution in the market
  • Key market player profiles, their recent developments, strategies, financial details, key competencies, presence by region, and product portfolio
  • Valuable insights, data, and forecast that can be referenced to plan business strategies, to tap market opportunities, understand business related risks, derive business goals, to recognize trends, and understand target customers/end users
  • Insights on recent technologies, pipeline products, regulations related with target market, market investment, and offers insights on political and economical factors that may influence market growth
  • PEST Analysis, PORTER’s five forces analysis, opportunity map analysis, drivers and restraints impact analysis, and market attractiveness index

Competitive Analysis

Advancements in the product as well as in manufacturing process, product launches, and strategic partnerships are some trends witnessed in the global intrauterine devices market. For instance, in 2016, Bayer AG launched hormonal IUD Kyleena and got U.S. FDA approval the sales and distribution of hormonal IUD in the country.

  • Actavis Pharma, Inc.
  • Bayer AG
  • Teva Pharmaceutical, Inc.
  • Allergen, Inc.
  • ANI Pharmaceuticals, Inc.
  • Eurogine Analytico BV
  • OCON Medical Ltd.
  • Pregna International Ltd.
  • SMB Corporation
  • HLL Lifecare Ltd.

Prophecy Market Insights offers required customization on this report according to specific business requirements.

Global Intrauterine Devices Market By Table of Contents

Research Objective and Assumption

  • Preface
  • Research Objectives
  • Study Scope
  • Years Considered for the study
  • Assumptions
  • Abbreviations

Research Methodology

  • Research data
  • Primary Data
    • Primary Interviews
    • Primary Breakdown
    • Key data from Primary Sources
    • Key Thickness Insights
  • Secondary Data
    • Major Secondary Sources
    • Secondary Sources
  • Market Estimation
  • Top-Down Approach
    • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
  • Bottom-Up Approach
    • Approach for estimating market share by Bottom-up Analysis (Demand Side)
  • Market Breakdown and Data Triangulation
  • Research Assumptions

Market Preview

  • Executive Summary
  • Key Findings—Global Outlook for medical carts Strategies
    • Key Questions this Study will Answer
    • Market Snippet, By Type
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Opportunity Map Analysis
  • Executive Summary—3 Big Predictions

Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restrains
    • Market Opportunities
    • Market Trends
  • DR Impact Analysis
  • PEST Analysis
  • Porter’s Five Forces Analysis
  • Opportunity Orbit
  • Market Investment Feasibility Index
  • Macroeconomic Factor Analysis

Inhalation Lactose Market, By Type, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Hormonal IUD
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Copper IUD
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Inhalation Lactose Market, By Distribution Channel, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Ambulatory Surgical Centers
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Obstructive & Gynecology Clinics
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Government & Non-Profit Organizations
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Inhalation Lactose Market, By Region, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Regional Trends
  • North America
    • Market Size and Forecast (US$ Bn), By Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By By Distribution Channel, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • U.S.
      • Canada
  • Europe
    • Market Size and Forecast (US$ Bn), By Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By By Distribution Channel, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • UK
      • France
      • Germany
      • Russia
      • Italy
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast (US$ Bn), By Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By By Distribution Channel, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • India
      • Japan
      • South Korea
      • China
      • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast (US$ Bn), By Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By By Distribution Channel, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • Brazil
  • Mexico
  • Rest of Latin America

 

  • Middle East & Africa
    • Market Size and Forecast (US$ Bn), By Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By By Distribution Channel, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East

Competitive Landscape

  • Heat Map Analysis
  • Market Presence and Specificity Analysis

Company Profiles

  • Actavis Pharma, Inc.
    • Company Overview
    • Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bayer AG
    • Company Overview
    • Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Teva Pharmaceutical, Inc.
    • Company Overview
    • Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Allergen, Inc.
    • Company Overview
    • Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • ANI Pharmaceuticals, Inc.
    • Company Overview
    • Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Eurogine Analytico BV
    • Company Overview
    • Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • OCON Medical Ltd.
    • Company Overview
    • Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Pregna International Ltd.
    • Company Overview
    • Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • SMB Corporation
    • Company Overview
    • Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • HLL Lifecare Ltd.
    • Company Overview
    • Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

The Last Word

  • Future Impact
  • About Us
  • Contact

FAQs

The Intrauterine Devices Market report segments the market been segmented on the basis of type, distribution channel, and region.

The Intrauterine Devices (IUD) market is expected to grow due to factors such as increasing awareness about contraception, favorable government initiatives, rising adoption of long-acting reversible contraception (LARC), and the growing demand for non-surgical birth control options.

Asia-Pacific rregion is dominating the Intrauterine Devices Market compared to that of other regions.

Actavis Pharma, Inc,Bayer AG,Teva Pharmaceutical, Inc,Allergen, Inc,ANI Pharmaceuticals, Inc.,Eurogine Analytico BV,OCON Medical Ltd,Pregna International Ltd,SMB Corporation,HLL Lifecare Ltd.